Protein Distribution and Leucine Supplementation Effects on Body Composition and Performance in Tactical Athletes

ConditionMuscle Damage
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-35
SponsorTel Aviv University

About this trial

This randomized controlled trial will examine the effects of within-day protein distribution and leucine supplementation on body composition, physical performance, and biomarkers of muscle damage in tactical athletes during an 8-week intensive training program. Sixty-nine healthy male participants (18-35 years) enrolled in a Ministry of Defense training course will be randomly assigned to one of three iso-caloric dietary groups providing 1.6 g/kg/day of protein: (1) evenly distributed protein across three meals (EVEN), (2) a 16-hour daily protein fasting pattern with protein concentrated at lunch and dinner (FAST), or (3) the same fasting pattern with 5 g leucine supplementation at breakfast (FAST-RESCUE).

Primary outcomes include changes in lean body mass. Secondary outcomes include strength, anaerobic performance, and biochemical markers of muscle damage, including urinary titin N-terminal fragment (UTF). Assessments will be conducted at baseline, Week 5, and Week 8.

Eligibility criteria

Qualifiers

Male participants aged 18-35 years

Enrolled in an active Ministry of Defense tactical training program

Physically active and medically cleared to participate in intensive training

Willing and able to comply with the dietary intervention and training protocol

Disqualifiers

Musculoskeletal or neuromuscular injury or impairment limiting participation in exercise training

Cardiopulmonary disease (including recent myocardial infarction or unstable angina)

History of cancer, diabetes, thyroid disease, hypertension, or chronic renal failure

Cognitive impairment affecting ability to provide informed consent

Trial design

Treatments tested in this trial

  • L-leucine supplementation
  • Even Protein Distribution
  • Skewed Protein Distribution (16-hour Protein-Fasting Window)

Treatment groups

69 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators